HCC Healthcare Agrees $500M SPAC Deal to List on Nasdaq
RFAM•HCC Healthcare signed a business combination agreement with RF Acquisition Corp III to list on Nasdaq at a US$500 million valuation with expected closing in Q4 2026. The combined entity will operate over 120 long-term care facilities totaling over 9,000 beds and manage services for more than 7,000 individuals in Northern Taiwan.
1. Business Combination Details
HCC Healthcare and RF Acquisition Corp III have entered into a business combination agreement that values HCC at US$500 million. The transaction is expected to close in the fourth quarter of 2026, pending shareholder approval, Form F-4 effectiveness, and customary closing conditions.
2. Pro Forma Integrated Network
On a pro forma basis, the combined entity will operate over 120 long-term care facilities totaling more than 9,000 beds, including a flagship 1,300-bed hospital-within-an-eldercare-institution model. The network will deliver medical transportation, consumables procurement, education, consulting, and manage services for over 7,000 community-based care cases.
3. Strategic Growth Roadmap
The group plans to deploy a proprietary AI platform for clinical decision support, expand into the Japanese market leveraging existing infrastructure, form wellness partnerships, and invest in precision and regenerative medicine to enhance personalized care across the region.
4. Use of Proceeds and Market Opportunity
Proceeds from the deal will fund consolidation and integration to expand service capacity and improve care coordination in Northern Taiwan. HCC aims to capitalize on Asia’s rapid transition to super-aged societies, addressing growing demand for coordinated medical and long-term care solutions.
